ISIN | LU0578134073 |
---|---|
Valor Number | 12424755 |
Bloomberg Global ID | BBG001JZG9T1 |
Fund Name | MEMNON FUND-Memnon European Fund I USD |
Fund Provider |
Zadig Gestion Luxembourg
Phone: +352 26 47 6301 Web: www.zadig.lu |
Fund Provider | Zadig Gestion Luxembourg |
Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
Distributor(s) | CACEIS (Switzerland) SA |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
Investment Strategy *** | The objective of this Sub-Fund is to maximise long term capital growth by investing primarily in quoted equity listed on or dealt in Regulated Markets within the EEA, UK and Switzerland which are issued by companies with principal offices in the EEA, UK and Switzerland. To achieve its investment objective, this Sub-Fund will base its investments on fundamental research in the selection of Transferable Securities for long positions. |
Peculiarities |
Current Price * | 418.40 USD | 01.07.2025 |
---|---|---|
Previous Price * | 417.47 USD | 30.06.2025 |
52 Week High * | 429.24 USD | 11.06.2025 |
52 Week Low * | 359.17 USD | 09.04.2025 |
NAV * | 418.40 USD | 01.07.2025 |
Issue Price * | 418.40 USD | 01.07.2025 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 391,314,508 | |
Unit/Share Assets *** | 352,186 | |
Trading Information SIX |
YTD Performance | +7.70% |
31.12.2024 - 01.07.2025
31.12.2024 01.07.2025 |
---|---|---|
YTD Performance (in CHF) | -6.16% |
31.12.2024 - 01.07.2025
31.12.2024 01.07.2025 |
1 month | +0.69% |
02.06.2025 - 01.07.2025
02.06.2025 01.07.2025 |
3 months | +3.04% |
01.04.2025 - 01.07.2025
01.04.2025 01.07.2025 |
6 months | +7.58% |
02.01.2025 - 01.07.2025
02.01.2025 01.07.2025 |
1 year | +11.10% |
01.07.2024 - 01.07.2025
01.07.2024 01.07.2025 |
2 years | +17.83% |
03.07.2023 - 01.07.2025
03.07.2023 01.07.2025 |
3 years | +46.21% |
01.07.2022 - 01.07.2025
01.07.2022 01.07.2025 |
5 years | +84.57% |
01.07.2020 - 01.07.2025
01.07.2020 01.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 6.48% | |
---|---|---|
Reckitt Benckiser Group PLC | 6.04% | |
Kerry Group PLC Class A | 5.77% | |
Continental AG | 5.76% | |
Merck KGaA | 5.41% | |
Roche Holding AG | 5.34% | |
Commerzbank AG | 4.95% | |
Shell PLC | 4.82% | |
Publicis Groupe SA | 4.76% | |
Renault SA | 4.66% | |
Last data update | 31.03.2025 |
TER | 0.36% |
---|---|
TER date | 31.07.2017 |
Performance Fee *** | 15.00% |
PTR | |
Max. Management Fee *** | 1.25% |
Ongoing Charges *** | 1.63% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |